Frequency distribution of C3435T mutation in exon 26 of the MDR1 gene in a Spanish population

被引:58
作者
Bernal, ML [1 ]
Sinues, B [1 ]
Fanlo, A [1 ]
Mayayo, E [1 ]
机构
[1] Univ Zaragoza, Fac Med, Dept Farmacol & Fisiol, Zaragoza, Spain
关键词
MDR1; gene; P-glycoprotein; Spanish population frequency;
D O I
10.1097/00007691-200302000-00016
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
P-glycoprotein (PGP) is a transmembrane efflux transporter with an important role in drug therapy. The level of PGP expression leads to relevant consequences in terms of efficacy and toxicity by modulating drug disposition. A single nucleotide polymorphism (SNP) in exon 26 of the MDR1 gene C3435T was recently associated to PGP levels and substrate uptake. Persons who were homozygous for the T-allele had significantly decreased PGP expression compared with C/C persons. Due to this fact and bearing in mind the important differences among populations regarding the frequencies of persons carrying mutations affecting drug disposition, the authors wanted to study the prevalence of this genetic trait in their population. DNA samples from 408 persons were assayed by a PCR-RFLP method. The results showed that the distributions of the C/C, T/T, and C/T genotypes in the Spanish population were 26%, 22%, and 52%, respectively. With regard the C-allele frequency, which has been studied in several populations, the result in their population was 52%, significantly lower (P < 0.0001) than that found in African populations and similar to several Asian and Caucasian (UK) populations (P > 0.05). By contrast, the C-allele frequency in southwest Asian, German, and Portuguese populations was significantly lower than in the Spanish population (P < 0.001, P < 0.01, and P < 0.05, respectively). The great differences found between their population and others, such as the African and southwest Asian populations, could have important therapeutic implications when drugs that are a substrate of PGP are used.
引用
收藏
页码:107 / 111
页数:5
相关论文
共 29 条
  • [1] GENETIC-BASIS FOR DIFFERENCES IN DEBRISOQUIN POLYMORPHISM BETWEEN A SPANISH AND OTHER WHITE-POPULATIONS
    AGUNDEZ, JAG
    MARTINEZ, C
    LEDESMA, MC
    LADONA, MG
    LADERO, JM
    BENITEZ, J
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1994, 55 (04) : 412 - 417
  • [2] Biochemical, cellular, and pharmacological aspects of the multidrug transporter
    Ambudkar, SV
    Dey, S
    Hrycyna, CA
    Ramachandra, M
    Pastan, I
    Gottesman, MM
    [J]. ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1999, 39 : 361 - 398
  • [3] MDR1 pharmacogenetics:: frequency of the C3435T mutation in exon 26 is significantly influenced by ethnicity
    Ameyaw, MM
    Regateiro, F
    Li, T
    Liu, XH
    Tariq, M
    Mobarek, A
    Thornton, N
    Folayan, GO
    Githang'a, J
    Indalo, A
    Ofori-Adjei, D
    Price-Evans, DA
    McLeod, HL
    [J]. PHARMACOGENETICS, 2001, 11 (03): : 217 - 221
  • [4] Ten percent of North Spanish individuals carry duplicated or triplicated CYP2D6 genes associated with ultrarapid metabolism of debrisoquine
    Bernal, ML
    Sinues, B
    Johansson, I
    McLellan, RA
    Wennerholm, A
    Dahl, ML
    Ingelman-Sundberg, M
    Bertilsson, L
    [J]. PHARMACOGENETICS, 1999, 9 (05): : 657 - 660
  • [5] Frequency of single nucleotide polymorphisms in the P-glycoprotein drug transporter MDR1 gene in white subjects
    Cascorbi, I
    Gerloff, T
    Johne, A
    Meisel, C
    Hoffmeyer, S
    Schwab, M
    Schaeffeler, E
    Eichelbaum, M
    Brinkmann, U
    Roots, I
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2001, 69 (03) : 169 - 174
  • [6] CHEN CJ, 1990, J BIOL CHEM, V265, P506
  • [7] Expression-based genetic/physical maps of single-nucleotide polymorphisms identified by the cancer genome anatomy project
    Clifford, R
    Edmonson, M
    Hu, Y
    Nguyen, C
    Scherpbier, T
    Buetow, KH
    [J]. GENOME RESEARCH, 2000, 10 (08) : 1259 - 1265
  • [8] DELPH Y, 2000, TAG BASIC SCI REPORT
  • [9] EXPRESSION OF A MULTIDRUG RESISTANCE GENE IN HUMAN CANCERS
    GOLDSTEIN, LJ
    GALSKI, H
    FOJO, A
    WILLINGHAM, M
    LAI, SL
    GAZDAR, A
    PIRKER, R
    GREEN, A
    CRIST, W
    BRODEUR, GM
    LIEBER, M
    COSSMAN, J
    GOTTESMAN, MM
    PASTAN, I
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (02) : 116 - 124
  • [10] P-glycoprotein and multidrug resistance
    Gottesman, MM
    Pastan, I
    Ambudkar, SV
    [J]. CURRENT OPINION IN GENETICS & DEVELOPMENT, 1996, 6 (05) : 610 - 617